The FDA is considering allowing compounding pharmacies to make unproven peptides—sparking fears around efficacy and safety.
From Looksmaxxing to FDA Approval? The U.S. Considers Greenlighting Mystery Peptides
You Might Also Like
Tim Cook’s Biggest Win Wasn’t the iPhone—It Was This $100 Billion Move
Cook laid the groundwork for Apple’s transition into a service-based powerhouse and grew the company to be worth about $4…
Lovable left AI prompts and user data exposed, one researcher found
A researcher revealed that the vibe-coding platform Lovable exposed users’ chat histories with AI models to other users accessing the…
How to navigate uncertainty in an increasingly uncertain world
The advancement of artificial intelligence has shifted rapidly from abstract curiosity to an immediate personal threat for millions of workers.…
What’s in a Name? When It Comes to Family Business, Everything
Recognize the value of your family name, and take steps to protect it.
